导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -18.63% | 4280/4773 |
| 近一周 | -3.52% | 4271/5462 |
| 近一月 | -11.30% | 5330/5421 |
| 近一季 | -19.44% | 4831/5209 |
| 近半年 | -20.34% | 4389/4920 |
| 近一年 | -13.32% | 3599/4366 |
| 近两年 | 55.54% | 1324/2954 |
| 近三年 | 19.11% | 1500/2253 |
| 成立以来 | 101.16% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-1.32% 2235/4961 |
1.91% 2980/5312 |
- - |
- - |
| 2025 | 48.02% 542/4813 |
7.72% 476/3635 |
-0.95% 3073/4076 |
44.70% 621/4524 |
-4.12% 3403/4813 |
| 2024 | 8.41% 1558/3463 |
-3.96% 1591/2808 |
-6.87% 2027/3014 |
22.52% 468/3129 |
-1.07% 1578/3463 |
| 2023 | -26.23% 1986/2656 |
-2.33% 1961/2280 |
-4.69% 1254/2385 |
-14.30% 2178/2515 |
-7.53% 2166/2655 |
| 2022 | -26.15% 1374/2207 |
-16.32% 1122/1919 |
18.56% 101/2016 |
-22.51% 1928/2113 |
-3.93% 1872/2208 |
| 2021 | 30.51% 67/1822 |
-12.36% 1146/1255 |
36.39% 26/1330 |
9.17% 143/1466 |
0.01% 1179/1822 |
| 2020 | 92.47% 20/1250 |
-5.52% 428/1028 |
22.04% 219/1067 |
15.27% 225/1164 |
44.81% 11/1184 |
| 2019 | 31.47% 468/1092 |
22.08% 578/754 |
-11.60% 768/804 |
3.69% 237/850 |
17.50% 14/918 |
| 2018 | -36.39% 589/834 |
- - |
- - |
- - |
-14.32% 578/691 |
| 2017 | 14.24% 258/714 |
- - |
- - |
- - |
- - |
| 2016 | -16.88% 389/605 |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 万家中证港股通创新药ETF | 1.5896 | 28.31% |
| 港股医疗ETF | 1.4282 | 28.15% |
| 天弘恒生沪深港创新药精选50ETF | 0.8437 | 27.35% |
| 华富中证港股通创新药指数型发起式A | 1.1464 | 27.24% |
| 嘉实中证港股通创新药指数发起式C | 0.8441 | 26.80% |
| 中欧中证港股通创新药指数发起A | 1.5868 | 26.75% |
| 中欧中证港股通创新药指数发起C | 1.4370 | 26.67% |
| 永赢中证港股通医疗主题ETF发起联接A | 0.8762 | 26.58% |
| 华夏中证港股通医疗主题ETF发起式联接A | 0.8585 | 26.45% |
| 华夏中证港股通医疗主题ETF发起式联接C | 0.8568 | 26.39% |
| 国泰国证新能源汽车指数A VS. 长安沪深300非周期A(740101) |